Genix Pharmaceuticals Corporation filed its Annual on Feb 28, 2023 for the period ending Oct 31, 2022. In this report its auditor, Harbourside CPA LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.04 CAD | -20.00% | -16.67% | +100.00% |
1st Jan change | Capi. | |
---|---|---|
+100.00% | 2.15M | |
+13.21% | 8.15B | |
-0.47% | 7.23B | |
+12.30% | 6.65B | |
-6.99% | 3.72B | |
-7.20% | 3.64B | |
-4.78% | 1.31B | |
+12.61% | 972M | |
-43.12% | 863M | |
-15.02% | 799M |
- Stock Market
- Equities
- GENX Stock
- News Genix Pharmaceuticals Corporation
- Genix Pharmaceuticals Corporation Auditor Raises 'Going Concern' Doubt